Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 13.36 USD 1.44% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Myriad Genetics Inc?
Write Note

Wall Street
Price Targets

MYGN Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYGN is 23.6 USD with a low forecast of 14.14 USD and a high forecast of 36.75 USD.

Lowest
Price Target
14.14 USD
6% Upside
Average
Price Target
23.6 USD
77% Upside
Highest
Price Target
36.75 USD
175% Upside

MYGN Last Price Targets
Myriad Genetics Inc

The latest public price target was made on Oct 14, 2024 by Sung Ji Nam from Scotiabank , who expects MYGN stock to rise by 154% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Sung Ji Nam
Scotiabank
34 USD
Upside 154%
2 months ago
Oct 14, 2024
Scotiabank Reiterates Sector Outperform Rating on Myriad Genetics (MYGN)
StreetInsider
Tejas Savant
Morgan Stanley
32 USD
Upside 140%
3 months ago
Sep 19, 2024
Myriad Genetics initiated with an Equal Weight at Morgan Stanley
TheFly
Brandon Couillard
Wells Fargo
35 USD
Upside 162%
3 months ago
Aug 27, 2024
Myriad Genetics initiated with an Overweight at Wells Fargo
TheFly
Subbu Nambi
Guggenheim
29 USD
Upside 117%
4 months ago
Aug 7, 2024
Myriad Genetics price target raised to $29 from $25 at Guggenheim
TheFly
Sung Ji Nam
Scotiabank
29 USD
Upside 117%
5 months ago
Jun 26, 2024
Myriad Genetics initiated with an Outperform at Scotiabank
TheFly
Jon Peterson
Piper Sandler
28 USD
Upside 110%
7 months ago
May 13, 2024
Myriad Genetics (MYGN) PT Raised to $28 at Piper Sandler
StreetInsider
David Westenberg
Piper Sandler
23 USD
Upside 72%
1 year ago
Dec 21, 2023
Genetic Testing Pioneer Myriad Genetics' Evolution Draws Analyst Attention Amid New Product(s) Anticipation
Benzinga
Show More Price Targets
Show Less Price Targets
Sung Ji Nam
Scotiabank
Price Target 34 USD
Upside/Downside 154%
View Source
Tejas Savant
Morgan Stanley
Price Target 32 USD
Upside/Downside 140%
View Source
Brandon Couillard
Wells Fargo
Price Target 35 USD
Upside/Downside 162%
View Source
Subbu Nambi
Guggenheim
Price Target 29 USD
Upside/Downside 117%
View Source
Sung Ji Nam
Scotiabank
Price Target 29 USD
Upside/Downside 117%
View Source
Jon Peterson
Piper Sandler
Price Target 28 USD
Upside/Downside 110%
View Source
David Westenberg
Piper Sandler
Price Target 23 USD
Upside/Downside 72%
View Source
Show More Price Targets
Show Less Price Targets
Myriad Genetics Inc Competitors:
Price Targets
006280
Green Cross Corp
17% Upside
INCY
Incyte Corp
17% Upside
KMDA
Kamada Ltd
154% Upside
688105
Nanjing Vazyme Biotech Co Ltd
9% Upside
VTGN
VistaGen Therapeutics Inc
390% Upside
ASND
Ascendis Pharma A/S
44% Upside
SNDX
Syndax Pharmaceuticals Inc
185% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
78% Upside

Revenue
Forecast

Revenue Estimate
Myriad Genetics Inc

For the last 2 years the compound annual growth rate for Myriad Genetics Inc's revenue is 4%. The projected CAGR for the next 4 years is 9%.

4%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYGN's stock price target?
Price Target
23.6 USD

According to Wall Street analysts, the average 1-year price target for MYGN is 23.6 USD with a low forecast of 14.14 USD and a high forecast of 36.75 USD.

What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
9%

For the last 2 years the compound annual growth rate for Myriad Genetics Inc's revenue is 4%. The projected CAGR for the next 4 years is 9%.

Back to Top